Bookmark

Add to MyYahoo RSS

Arena Pharmaceuticals News

News on Arena Pharmaceuticals (Ticker: ARNA) continually updated from thousands of sources around the net.

14 hrs ago | BioSpace

Eisai Inc. And Arena Pharmaceuticals, Inc. Announce BELVIQ??...

Award is considered one of the biomedical industry's top accolades. It recognizes outstanding achievements in improving the human condition through the development of innovative therapies.

Comment?

Related Topix: Biotech, Medicine, Eisai, Healthcare Industry, Food and Drug Administration, Diabetes, Health, Depression

Mon Jul 28, 2014

Seeking Alpha

Arena Conference Call Sets Stage For Near Term Equity Movement

Arena Pharmaceuticals will be hosting its quarterly conference call on Friday, August 1st, 2014 at 8:00 AM Eastern time.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Fri Jul 25, 2014

Freshnews

Arena Pharmaceuticals to Host Corporate Update and Financial Results...

Arena Pharmaceuticals, Inc. today announced that it will provide a corporate update and report second quarter 2014 financial results before the NASDAQ Global Select Market opens on Friday, August 1, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing

Mon Jul 21, 2014

San Diego Source

Arena subsidiary enters agreement with Israeli distributor for weight loss drug

Arena Pharmaceuticals Inc . announced on Monday that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement with Abic Marketing Limited, a Teva Pharmaceutical Industries subsidiary, for its weight loss and management product Belviq.

Comment?

Related Topix: Israel, World News, Middle East, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing, Teva Pharmaceutical Industries

Fri Jul 18, 2014

Seeking Alpha

Arena Stock Rises With Expected Jump In Belviq Sales

This week, we saw an anticipated pop in prescription numbers for the anti-obesity pill Belviq from Arena Pharmaceuticals .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing

Tue Jul 15, 2014

Applied Clinical Trials

Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office

8,778,950, entitled "Cannabinoid Receptor Modulators," by the United States Patent and Trademark Office for APD371, an agonist of the cannabinoid receptor 2 .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Patent / Trademark Law, Law

Thu Jul 10, 2014

Freshnews

Arena Pharmaceuticals Reports that Eisai Completes Planned Increase...

Arena Pharmaceuticals, Inc. today reported that Eisai Inc. has completed its planned increase of more than 200 new contract sales representatives in its Metabolic Business Unit, increasing the sales force for BELVIQ by 50% to approximately 600.

Comment?

Related Topix: Biotech, Medicine, Eisai, Healthcare Industry, Arena Pharmaceuticals, Sales, Food and Drug Administration

Mon Jul 07, 2014

Seeking Alpha

Arena Prescription Sales OK - CEO Sales Are Not

Sales of Arena Pharmaceuticals prescription anti-obesity drug Belviq are in and are okay this week.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

TheStreet.com

Why Arena Pharmaceuticals (ARNA) Stock Is Dropping Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Mozilla, TheStreet, Financial Markets

TheStreet.com

Why Arena Pharmaceuticals (ARNA) Stock Is Dropping Today

TheStreet has in-depth coverage of the sale here . TheStreet Ratings team rates ARENA PHARMACEUTICALS INC as a Sell with a ratings score of D. TheStreet Ratings Team has this to say about their recommendation: "We rate ARENA PHARMACEUTICALS INC a SELL.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Benzinga

Arena Pharmaceutical Shares Dive On News CEO Sold 40% Of His Shares

Arena Pharmaceuticals shares plunged Monday on news that its chief executive Jack Lief sold nearly 40 percent of his holdings in the company.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Thu Jul 03, 2014

AmericanBankingNews.com

Arena Pharmaceuticals CEO Unloads $1,307,621 in Stock

Arena Pharmaceuticals CEO Jack Lief sold 223,525 shares of Arena Pharmaceuticals stock in a transaction that occurred on Tuesday, July 1st.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Mon Jun 30, 2014

AmericanBankingNews.com

Insider Selling: Arena Pharmaceuticals Director Sells 2,473 Shares of Stock

Arena Pharmaceuticals Director Donald D. Belcher unloaded 2,473 shares of the company's stock in a transaction dated Friday, June 27th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••